Navigation Links
University of Minnesota Receives $40 Million for Type 1 Diabetes Research
Date:12/11/2008

MINNEAPOLIS and ST. PAUL, Minn., Dec. 11 /PRNewswire/ -- The University of Minnesota has received a $40 million pledge for diabetes research from the Richard M. Schulze Family Foundation. Goals for the funding, to be paid over five years, are to capitalize on the University's strength in diabetes research and to accelerate the timeline to translate it into a viable cure for people with type 1 diabetes.

The gift is the second largest in the history of the University and the second largest by an individual or family foundation to diabetes research in the United States. In recognition of the gift and the future of diabetes research, the University will rename its Diabetes Institute for Immunology and Transplantation (DIIT) the Schulze Diabetes Institute.

"We have the capacity to cure this devastating disease and help people enjoy a happy and productive life no longer constrained by diabetes and constant fears and worries," said Bernhard Hering, M.D., an internationally recognized diabetes researcher and co-director of the Schulze Diabetes Institute. "Curing type 1 diabetes is possible. We only need to declare it possible, engage the brightest minds, be contagiously committed and break all barriers. This gift, for which we are very grateful, is breaking big barriers by boosting resources, raising awareness and injecting a sense of urgency and responsibility."

Type 1 diabetes is a crippling and relentless disease. It occurs in children and young adults when the immune system mistakenly destroys all insulin-producing islet beta cells in the pancreas. To stay alive and to regulate their blood sugar, patients rely on multiple daily blood sugar measurements and insulin injections. Even with rigorous disease management, they are at risk of developing deadly complications.

"This transformative gift enables some of the world's best minds to aggressively pursue a cure for a disease
'/>"/>

SOURCE University of Minnesota
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NOVAVAX and the University of Massachusetts Medical School Announce Preclinical Study Results for a Respiratory Syncytial Virus (RSV) Vaccine Candidate
2. Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market
3. Delcath Adds University of Pittsburgh Medical Center to Phase III Trial
4. University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells
5. Full Sail University Welcomed Back to Campus Graduate and Acclaimed Horror Director, Darren Lynn Bousman
6. Convey Computer™ Corporation Announces First Customer: University of California, San Diego at SC08 Conference
7. SpineSmith Partners Collaborates with University of Texas Biomedical Engineering Students to Develop Innovative Products
8. Nikon Instruments Provides Donation to Help Clemson University Start New Core Microscopy Facility
9. Medical Simulation Corporation Announces Partnership With University of South Florida
10. Winning University of Melbourne Ph.D. research boosts the search for sensitive sensors
11. Study From the University of Texas M.D. Anderson Cancer Center Demonstrates That AHCC(R) is Safe in Combination With Most Chemotherapeutic Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... 2015 Regis Technologies announced new ... oncology drug substances. , Regis Technologies is proud to ... Potent Compound Suite (PCS) for 2015. , Regis is ... cGMP facility in Morton Grove, Illinois. The PCS addition ... compounds up to about one kilogram per batch. ...
(Date:2/26/2015)... -- Epic Sciences announced today that President and CEO ... Annual Cowen and Company Health Care Conference on Wednesday, March ... Floor. The conference will be held at the Boston ... is developing diagnostic tests of high clinical utility to ... occur during the course of cancer treatments. From a ...
(Date:2/26/2015)... , Feb. 26, 2015 CytomX, a ... cancer, today announced that Sean McCarthy , D. ... at the upcoming Cowen and Company 35 th ... . Dr. McCarthy,s presentation will take place at 4 ... CytomX Therapeutics CytomX Therapeutics develops Probody™ therapeutics for ...
(Date:2/26/2015)... LONDON , February 26, 2015 ... of subjects into PEACH, the first pivotal trial ... dialysis dependent chronic kidney disease (DD-CKD), has completed ... achieved. PT20, invented by leading UK-based ... licensed by Phosphate Therapeutics, is a novel phosphate ...
Breaking Biology Technology:Regis Extends cGMP Services to Oncology Market 2Epic Sciences to Present at 35th Annual Cowen and Company Health Care Conference 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 2Phosphate Therapeutics Announces Completion of Subject Recruitment Into the PEACH Pivotal Phase 2 Study of its Novel Phosphate Binder (PT20) for the Treatment of Hyperphosphataemia 3
... physicists have successfully landed a one-two punch on a ... then dosing its perimeter with a laser beam, to ... standstill. The findings, published in Nature Physics ... special quantum properties and in precision-measurements for nanotechnology. The ...
... N.C., June 17 Pharmaceutical Institute (PI), a leading provider ... today announced the release of a new e-course titled, ... newest addition to the company,s Managed Markets Excellence(TM) ... e-course provides a comprehensive overview of the challenges confronting the ...
... (NYSE: DGX ), the world,s leading provider of ... for its previously announced cash tender offer to purchase up ... of its 5.125% Senior Notes due 2010 and 7.50% Senior ... conditions of the tender offer are described in the Offer ...
Cached Biology Technology:Pharmaceutical Institute Launches New E-Course Focused on Health Policy 2Pharmaceutical Institute Launches New E-Course Focused on Health Policy 3Quest Diagnostics Announces Final Tender Offer Results 2Quest Diagnostics Announces Final Tender Offer Results 3
(Date:2/24/2015)... , Feb. 24, 2015 This report analyzes the ... the following Segments: Face Biometrics, and Voice Biometrics. The report provides ... Japan , Europe , ... Africa , and Latin America ... through 2020. Also, a seven-year historic analysis is provided for these ...
(Date:2/19/2015)... , Feb .19, 2015 Research and ... the addition of the "Military Electro-Optical / ... Sensor Technology, by Platform - Forecast to 2020" ... The military electro-optical/infrared systems market is expected to ... CAGR of 7.71%. This report segments ...
(Date:2/12/2015)... Minn. , Feb. 12, 2015   ... company specializing in clinical study management systems, has ... Program , further distinguishing iMedNet ... Clinical Research Organizations (CROs) and healthcare consultants.  Building ... support, prospective customer referrals and numerous co-marketing opportunities), ...
Breaking Biology News(10 mins):World Face and Voice Biometrics Industry 2World Face and Voice Biometrics Industry 3World Face and Voice Biometrics Industry 4World Face and Voice Biometrics Industry 5World Face and Voice Biometrics Industry 6World Face and Voice Biometrics Industry 7World Face and Voice Biometrics Industry 8World Face and Voice Biometrics Industry 9World Face and Voice Biometrics Industry 10World Face and Voice Biometrics Industry 11World Face and Voice Biometrics Industry 12World Face and Voice Biometrics Industry 13World Face and Voice Biometrics Industry 14World Face and Voice Biometrics Industry 15World Face and Voice Biometrics Industry 16Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 2Military Electro-Optical / Infrared Systems (Image Intensification, Laser, Infrared) Market - Forecast to 2020: Featuring Profiles of the Market Leaders on this $16 Billion market 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2
... tumors often fail to respond to promising new medication. ... tumor marker for the development of this resistance. A ... great the chances of success are for chemotherapy. At ... promising brain tumor therapy. Dr. Wolf Mller, senior ...
... first information about how fat causes hypertension have been identified ... identify which obese people and maybe some thin ones ... would work best for them. Medical College of ... PTP1B puts mice at risk for hypertension by interfering with ...
... introduced to the U.S. from Europe and other places, garlic ... new study indicates that eventually, however, its primary weapon ... potent. The study, in Proceedings of the National ... show that evolutionary forces can alter the very attributes that ...
Cached Biology News:Why don't brain tumors respond to medication? 2New information about how fat increases blood pressure could help identify those at risk 2New information about how fat increases blood pressure could help identify those at risk 3Over time, an invasive plant loses its toxic edge 2Over time, an invasive plant loses its toxic edge 3
... APO-BRDU Kit is a two color staining ... cellular DNA to detect apoptotic cells by ... and reagents required for measuring apoptosis in ... for assessing reagent performance; washing, reaction and ...
... The CHEMICON APO-BRDU Kit is ... labeling DNA breaks and total cellular DNA ... The kit contains the instructions and ... including; positive and negative control cells for ...
... PowerPac HV high-voltage power supply, with temperature probe, ... of 5,000 V, 500 mA, and 400 W. ... temperature between 0 and 90 degrees C during ... transfer. Power cord and instructions are provided. Dimensions ...
The Trans-Blot Plus gel and cassette assembly tray is used to hold the Trans-Blot Plus gel holder cassette, buffer, and other materials for the gel and membrane sandwich during their assembly....
Biology Products: